Friday, November 20, 2026

english

HAUT MONDE

POST

Technology

• Analysis

Polymarket and Kalshi health betting markets now cover measles and FDA approvals

The online prediction markets Polymarket and Kalshi now host bets on US public health events, including measles case counts in 2026, FDA vaccine approvals and CDC vaccine recommendations - and experts warn the largely unregulated contracts resemble gambling.

By Haut Monde Post

• November 15, 2026

• 5 Min Read

Polymarket and Kalshi health betting markets now cover measles and FDA approvals

Betting on public health has arrived. Polymarket, an online prediction market where users can wager on the outcome of nearly any event, has extended its offering to US health outcomes, and Kalshi began listing health-related predictions over the summer. Researchers who study gambling say the polymarket kalshi health betting markets operate largely outside the rules that govern regulated gambling in the United States.

From measles counts to FDA approvals

The contracts on offer run from drug development to disease surveillance. Users can wager on:

  • •when the US Food and Drug Administration (FDA) will approve a skin-cancer vaccine
  • •whether the CDC will change its vaccine recommendations
  • •drug trial outcomes and approvals
  • •the US measles case count for 2026, and whether the country keeps its measles-elimination status this year
  • •when certain officials will leave health agencies

The markets have also moved into the street. Polymarket posted an advertisement on a construction fence beside an elementary school in the Brooklyn borough of New York City that read 'Vaccines' but asked, alongside its logo, 'Will any state end vaccine markets?' Within a week the sign was vandalized: the bottom strip carrying the logo and prediction text was ripped away, leaving it reading simply 'Vaccines'.

Regulators and the gambling label

The companies place their event contracts not in the gambling category but in finance. According to Lia Nower, professor and director of the Center for Gambling Studies at Rutgers University, prediction markets present themselves as financial derivatives, operating under federal commodities laws with oversight from the US Commodity Futures Trading Commission rather than state gambling regulators - even though, she said, they are functionally identical to regulated gambling while remaining largely unregulated.

"Gambling right now is like the wild, wild west."

That is Nower's description of the current landscape: no federal regulatory body prescribes limits. Several states have filed lawsuits against the prediction market companies alleging that they function as gambling sites.

Conflict-of-interest and insider risks

Matthew Eisenberg, who chairs health policy and management at the Johns Hopkins Bloomberg School of Public Health, said the expansion came as no surprise to him, because "Kalshi and Polymarket will list contracts on anything with a checkable outcome." But contracts on FDA decisions and trial endpoints, he said, "create a payoff for anyone with nonpublic information" - agency reviewers, trial investigators and legislative staff among them.

The platforms could build safeguards such as employment checks at sign-up, Eisenberg said, "but the risk isn't necessarily that a reviewer takes a bribe – it's that the market now rewards leaks."

Critics also warn that predictions could shape how drugs are tested and regulated: trial participants could purposefully change their behavior to affect outcomes, and drug companies could alter trial timing. Nower raised a further scenario - advocates, officials and lawmakers could place bets on ending state vaccine mandates and then introduce laws or policies to do so, with no apparent laws against it.

Harm and the companies' response

Nower frames gambling as a big public health issue, with the heaviest burden falling on people who are younger, Black or Hispanic and lower-income. In a report she co-authored, more than half of respondents aged 13 to 27 had gambled in the past year - and within that group, 39.5% carried some degree of gambling-related risk while 10.3% screened as high risk for problem gambling.

Eisenberg's own research found that online sports betting legalization is followed by measurable increases in treatment for depression and anxiety among young men. States, he noted, do maintain consumer protections - deposit limits, self-exclusion, advertising rules and treatment funding - but prediction markets sit outside all of that, with little revenue flowing to states through taxes. His verdict: "In effect, these are gambling products that have exited the only regulatory system designed to limit gambling harm."

The companies' response:

  • •Polymarket did not respond to questions about the potential consequences for public health or medicine.
  • •Kalshi did not respond on the record, but spokesperson Dani Lever argued that predictions on drug trials and approvals would improve transparency.
  • •Lever said Kalshi's clinical trial markets are a pilot program aimed at a structural problem in drug development, and that "Public markets avoid those barriers."

Eisenberg also cautioned against over-reading the markets themselves. Public-health propositions on the platforms are small, he said, and "Prices that small can be moved by a single trader and shouldn't be read as public opinion." As he put it, "A few-hundred-dollar contract on the childhood vaccine schedule is not a forecast of anything."

Nower said prediction markets are something the government needs to clamp down on, but the federal government has no gambling regulator and, unlike for alcohol and drug abuse, no research centers at the National Institutes of Health focused on gambling. States such as New Jersey are working to restrict the markets, citing consumer protection and the potential for insider trading on 'event contracts'. Eisenberg's expectation is broader still: "Gambling on everything, everywhere, with fewer and fewer consumer protections."

HAUT MONDE POST

Independent journalism of the highest standard. A chronicle of world culture, politics, arts, and public thought.

Publication

AboutEditorial

Newsletter

Get the best Haut Monde Post content delivered to your inbox every week.

© 2026 Haut Monde Post. All rights reserved. Digital edition hautmondepost.com.

Friday, Nov 20, 2026

english

Technology

• Analysis

Polymarket and Kalshi health betting markets now cover measles and FDA approvals

The online prediction markets Polymarket and Kalshi now host bets on US public health events, including measles case counts in 2026, FDA vaccine approvals and CDC vaccine recommendations - and experts warn the largely unregulated contracts resemble gambling.

By Haut Monde Post

Nov 15, 2026 • 5 Min Read
Polymarket and Kalshi health betting markets now cover measles and FDA approvals

Betting on public health has arrived. Polymarket, an online prediction market where users can wager on the outcome of nearly any event, has extended its offering to US health outcomes, and Kalshi began listing health-related predictions over the summer. Researchers who study gambling say the polymarket kalshi health betting markets operate largely outside the rules that govern regulated gambling in the United States.

From measles counts to FDA approvals

The contracts on offer run from drug development to disease surveillance. Users can wager on:

  • •when the US Food and Drug Administration (FDA) will approve a skin-cancer vaccine
  • •whether the CDC will change its vaccine recommendations
  • •drug trial outcomes and approvals
  • •the US measles case count for 2026, and whether the country keeps its measles-elimination status this year
  • •when certain officials will leave health agencies

The markets have also moved into the street. Polymarket posted an advertisement on a construction fence beside an elementary school in the Brooklyn borough of New York City that read 'Vaccines' but asked, alongside its logo, 'Will any state end vaccine markets?' Within a week the sign was vandalized: the bottom strip carrying the logo and prediction text was ripped away, leaving it reading simply 'Vaccines'.

Regulators and the gambling label

The companies place their event contracts not in the gambling category but in finance. According to Lia Nower, professor and director of the Center for Gambling Studies at Rutgers University, prediction markets present themselves as financial derivatives, operating under federal commodities laws with oversight from the US Commodity Futures Trading Commission rather than state gambling regulators - even though, she said, they are functionally identical to regulated gambling while remaining largely unregulated.

"Gambling right now is like the wild, wild west."

That is Nower's description of the current landscape: no federal regulatory body prescribes limits. Several states have filed lawsuits against the prediction market companies alleging that they function as gambling sites.

Conflict-of-interest and insider risks

Matthew Eisenberg, who chairs health policy and management at the Johns Hopkins Bloomberg School of Public Health, said the expansion came as no surprise to him, because "Kalshi and Polymarket will list contracts on anything with a checkable outcome." But contracts on FDA decisions and trial endpoints, he said, "create a payoff for anyone with nonpublic information" - agency reviewers, trial investigators and legislative staff among them.

The platforms could build safeguards such as employment checks at sign-up, Eisenberg said, "but the risk isn't necessarily that a reviewer takes a bribe – it's that the market now rewards leaks."

Critics also warn that predictions could shape how drugs are tested and regulated: trial participants could purposefully change their behavior to affect outcomes, and drug companies could alter trial timing. Nower raised a further scenario - advocates, officials and lawmakers could place bets on ending state vaccine mandates and then introduce laws or policies to do so, with no apparent laws against it.

Harm and the companies' response

Nower frames gambling as a big public health issue, with the heaviest burden falling on people who are younger, Black or Hispanic and lower-income. In a report she co-authored, more than half of respondents aged 13 to 27 had gambled in the past year - and within that group, 39.5% carried some degree of gambling-related risk while 10.3% screened as high risk for problem gambling.

Eisenberg's own research found that online sports betting legalization is followed by measurable increases in treatment for depression and anxiety among young men. States, he noted, do maintain consumer protections - deposit limits, self-exclusion, advertising rules and treatment funding - but prediction markets sit outside all of that, with little revenue flowing to states through taxes. His verdict: "In effect, these are gambling products that have exited the only regulatory system designed to limit gambling harm."

The companies' response:

  • •Polymarket did not respond to questions about the potential consequences for public health or medicine.
  • •Kalshi did not respond on the record, but spokesperson Dani Lever argued that predictions on drug trials and approvals would improve transparency.
  • •Lever said Kalshi's clinical trial markets are a pilot program aimed at a structural problem in drug development, and that "Public markets avoid those barriers."

Eisenberg also cautioned against over-reading the markets themselves. Public-health propositions on the platforms are small, he said, and "Prices that small can be moved by a single trader and shouldn't be read as public opinion." As he put it, "A few-hundred-dollar contract on the childhood vaccine schedule is not a forecast of anything."

Nower said prediction markets are something the government needs to clamp down on, but the federal government has no gambling regulator and, unlike for alcohol and drug abuse, no research centers at the National Institutes of Health focused on gambling. States such as New Jersey are working to restrict the markets, citing consumer protection and the potential for insider trading on 'event contracts'. Eisenberg's expectation is broader still: "Gambling on everything, everywhere, with fewer and fewer consumer protections."

HAUT MONDE POST

Independent journalism of the highest standard. A chronicle of world culture, politics, arts, and public thought. Published and printed daily in Paris, France.

Publication

AboutEditorial

Newsletter

Get the best Haut Monde Post content delivered to your inbox every week.

© 2026 Haut Monde Post. All rights reserved. Digital edition hautmondepost.com. Published in Paris.

Friday, Nov 20, 2026

english

Technology

• Analysis

Polymarket and Kalshi health betting markets now cover measles and FDA approvals

The online prediction markets Polymarket and Kalshi now host bets on US public health events, including measles case counts in 2026, FDA vaccine approvals and CDC vaccine recommendations - and experts warn the largely unregulated contracts resemble gambling.

By Haut Monde Post

Polymarket and Kalshi health betting markets now cover measles and FDA approvals

Betting on public health has arrived. Polymarket, an online prediction market where users can wager on the outcome of nearly any event, has extended its offering to US health outcomes, and Kalshi began listing health-related predictions over the summer. Researchers who study gambling say the polymarket kalshi health betting markets operate largely outside the rules that govern regulated gambling in the United States.

From measles counts to FDA approvals

The contracts on offer run from drug development to disease surveillance. Users can wager on:

  • •when the US Food and Drug Administration (FDA) will approve a skin-cancer vaccine
  • •whether the CDC will change its vaccine recommendations
  • •drug trial outcomes and approvals
  • •the US measles case count for 2026, and whether the country keeps its measles-elimination status this year
  • •when certain officials will leave health agencies

The markets have also moved into the street. Polymarket posted an advertisement on a construction fence beside an elementary school in the Brooklyn borough of New York City that read 'Vaccines' but asked, alongside its logo, 'Will any state end vaccine markets?' Within a week the sign was vandalized: the bottom strip carrying the logo and prediction text was ripped away, leaving it reading simply 'Vaccines'.

Regulators and the gambling label

The companies place their event contracts not in the gambling category but in finance. According to Lia Nower, professor and director of the Center for Gambling Studies at Rutgers University, prediction markets present themselves as financial derivatives, operating under federal commodities laws with oversight from the US Commodity Futures Trading Commission rather than state gambling regulators - even though, she said, they are functionally identical to regulated gambling while remaining largely unregulated.

"Gambling right now is like the wild, wild west."

That is Nower's description of the current landscape: no federal regulatory body prescribes limits. Several states have filed lawsuits against the prediction market companies alleging that they function as gambling sites.

Conflict-of-interest and insider risks

Matthew Eisenberg, who chairs health policy and management at the Johns Hopkins Bloomberg School of Public Health, said the expansion came as no surprise to him, because "Kalshi and Polymarket will list contracts on anything with a checkable outcome." But contracts on FDA decisions and trial endpoints, he said, "create a payoff for anyone with nonpublic information" - agency reviewers, trial investigators and legislative staff among them.

The platforms could build safeguards such as employment checks at sign-up, Eisenberg said, "but the risk isn't necessarily that a reviewer takes a bribe – it's that the market now rewards leaks."

Critics also warn that predictions could shape how drugs are tested and regulated: trial participants could purposefully change their behavior to affect outcomes, and drug companies could alter trial timing. Nower raised a further scenario - advocates, officials and lawmakers could place bets on ending state vaccine mandates and then introduce laws or policies to do so, with no apparent laws against it.

Harm and the companies' response

Nower frames gambling as a big public health issue, with the heaviest burden falling on people who are younger, Black or Hispanic and lower-income. In a report she co-authored, more than half of respondents aged 13 to 27 had gambled in the past year - and within that group, 39.5% carried some degree of gambling-related risk while 10.3% screened as high risk for problem gambling.

Eisenberg's own research found that online sports betting legalization is followed by measurable increases in treatment for depression and anxiety among young men. States, he noted, do maintain consumer protections - deposit limits, self-exclusion, advertising rules and treatment funding - but prediction markets sit outside all of that, with little revenue flowing to states through taxes. His verdict: "In effect, these are gambling products that have exited the only regulatory system designed to limit gambling harm."

The companies' response:

  • •Polymarket did not respond to questions about the potential consequences for public health or medicine.
  • •Kalshi did not respond on the record, but spokesperson Dani Lever argued that predictions on drug trials and approvals would improve transparency.
  • •Lever said Kalshi's clinical trial markets are a pilot program aimed at a structural problem in drug development, and that "Public markets avoid those barriers."

Eisenberg also cautioned against over-reading the markets themselves. Public-health propositions on the platforms are small, he said, and "Prices that small can be moved by a single trader and shouldn't be read as public opinion." As he put it, "A few-hundred-dollar contract on the childhood vaccine schedule is not a forecast of anything."

Nower said prediction markets are something the government needs to clamp down on, but the federal government has no gambling regulator and, unlike for alcohol and drug abuse, no research centers at the National Institutes of Health focused on gambling. States such as New Jersey are working to restrict the markets, citing consumer protection and the potential for insider trading on 'event contracts'. Eisenberg's expectation is broader still: "Gambling on everything, everywhere, with fewer and fewer consumer protections."